Prime-boost immunization with DNA vaccine: Mucosal route of administration changes the rules

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5473-5479

  Eo, S K ^a   Gierynska, M ^a   Kamar, A A ^a   Rouse, B T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

EID: 0035339883     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5473     Document Type: Article

References (29)

1. DNA vaccine: Immunology, application, and optimization
2. DNA vaccine for immunodeficiency virus
3. Generation of enhanced immune responses by consecutive immunization with DNA and recombinant fowlpox viruses
4. Potent, protective anti-HIV-immune responses generated by bimodal HIV envelope DNA plus protein vaccination
5. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaque
6. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
7. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine
8. Mucosal immunity and infections
9. + T lymphocytes
10. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization
11. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract
12. The involvement of an ATP dependent chaperone in the cross-presentation after DNA immunization
13. Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes
14. Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines
15. The cytotoxic T-cell response to herpes simplex virus type I infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant
16. Junctional biases in the naive TCR repertoire control the CTL responses to an immunodominant determinant of HSV-1
17. Development of a preventive vaccine for Ebola virus infection in primates
18. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowl pox virus
19. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
20. Immunization with polynucleotides: A novel approach to vaccination
21. Exposing the immunology of naked DNA vaccines
22. + cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12
23. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
24. Role of mucosal immunity in herpes simplex virus infection
25. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity
26. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10
27. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein
28. Influence of maternal antibodies on vaccine responses, inhibition of antibody but T cell responses allows successful early prime-boost strategies in mice
29. DNA immunization of neonates induces immunity despite the presence of maternal antibody